Compounds > theophylline

theophylline and sulfapyridine

theophylline has been researched along with sulfapyridine in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Boersma, YL; Dekker, FJ; Dömling, ASS; Eleftheriadis, N; Wójcik, M; Zwinderman, MRH1
Fujioka, Y; Higaki, K; Kimura, T; Metsugi, Y; Ogawara, K1

Other Studies

4 other study(ies) available for theophylline and sulfapyridine

ArticleYear
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Identification of potential antivirulence agents by substitution-oriented screening for inhibitors of Streptococcus pyogenes sortase A.
    European journal of medicinal chemistry, 2019, Jan-01, Volume: 161

    Topics: Aminoacyltransferases; Anti-Bacterial Agents; Bacterial Proteins; Cysteine Endopeptidases; Dose-Response Relationship, Drug; Drug Design; Drug Evaluation, Preclinical; Enzyme Inhibitors; Kinetics; Microbial Sensitivity Tests; Molecular Structure; Streptococcus pyogenes; Structure-Activity Relationship

2019
Evaluation of in vivo dissolution behavior and GI transit of griseofulvin, a BCS class II drug.
    International journal of pharmaceutics, 2008, Mar-20, Volume: 352, Issue:1-2

    Topics: Administration, Oral; Animals; Antifungal Agents; Cecum; Gastric Emptying; Gastrointestinal Transit; Griseofulvin; Injections, Intravenous; Intestinal Absorption; Male; Models, Biological; Powders; Rats; Rats, Wistar; Solubility; Sulfapyridine; Theophylline

2008